G. Stähler

1.1k total citations
18 papers, 652 citations indexed

About

G. Stähler is a scholar working on Pulmonary and Respiratory Medicine, Biochemistry and Genetics. According to data from OpenAlex, G. Stähler has authored 18 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 3 papers in Biochemistry and 2 papers in Genetics. Recurrent topics in G. Stähler's work include Pulmonary Hypertension Research and Treatments (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). G. Stähler is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). G. Stähler collaborates with scholars based in Germany, United Kingdom and United States. G. Stähler's co-authors include Jürgen Behr, Isabelle Leconte, Sébastiên Roux, Kevin M. Brown, Lisa Lancaster, Roland M. du Bois, João A. de Andrade, Talmadge E. King, Ganesh Raghu and Werner Seeger and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Journal of Molecular Medicine.

In The Last Decade

G. Stähler

17 papers receiving 633 citations

Peers

G. Stähler

PRM

PHYSI

CCM

SURGE

PFM

Mobeen Iqbal United States

G Hulks United Kingdom

Mitsunori Kamigaki Japan

Naobumi Mise Japan

Janny Takens Netherlands

Dimitrios Botsios Greece

L Marosi Austria

Ester Spagnolli United States

Yoko Yumino Japan

Yoshitaka Okuhara Japan

Mobeen Iqbal United States

G. Stähler

401 ×0.7

PRM

67 ×0.4

PHYSI

107 ×0.9

CCM

112 ×2.1

SURGE

24 ×0.5

PFM

Citations per year, relative to G. Stähler G. Stähler (= 1×) peers Mobeen Iqbal

Countries citing papers authored by G. Stähler

Since Specialization

Citations

This map shows the geographic impact of G. Stähler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Stähler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Stähler more than expected).

Fields of papers citing papers by G. Stähler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Stähler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Stähler. The network helps show where G. Stähler may publish in the future.

Co-authorship network of co-authors of G. Stähler

This figure shows the co-authorship network connecting the top 25 collaborators of G. Stähler. A scholar is included among the top collaborators of G. Stähler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Stähler. G. Stähler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kovács, Gábor, Daniel Dumitrescu, Sebastian Greiner, et al.. (2018). Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 11–19. 57 indexed citations

Halank, Michael, Marius M. Hoeper, Hossein Ardeschir Ghofrani, et al.. (2017). Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study. Respiratory Medicine. 128. 50–56. 29 indexed citations

Kovács, György, D. Dumitrescu, Stefan Greiner, et al.. (2016). Klinische Klassifikation der pulmonalen Hypertonie und initiale Diagnostik: Empfehlungen der Kölner Konsensus Konferenz 2016. DMW - Deutsche Medizinische Wochenschrift. 141(S 01). S10–S18. 5 indexed citations

Hoeper, Marius M., Hossein Ardeschir Ghofrani, Michael Halank, et al.. (2015). Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study. PA4560–PA4560. 1 indexed citations

Meyer, F. Joachim, Mathias M. Borst, Ralf Ewert, et al.. (2013). Belastungsuntersuchungen in der Pneumologie. Pneumologie. 67(1). 16–34. 25 indexed citations

Walterspacher, Stephan, Damian Walker, Nicola Ehlken, et al.. (2013). (Atem-)Training verbessert die Atemmuskelkraft bei pulmonaler Hypertonie. Pneumologie. 67(S 01). 3 indexed citations

Ghofrani, Hossein Ardeschir, Marius M. Hoeper, Michael Halank, et al.. (2012). Riociguat For Chronic Thromboembolic Pulmonary Hypertension And Pulmonary Arterial Hypertension: Long-Term Safety, Tolerability, And Efficacy. A2370–A2370. 3 indexed citations

Behr, J, Hossein Ardeschir Ghofrani, G. Stähler, et al.. (2011). Riociguat bei Patienten mit pulmonaler Hypertonie aufgrund einer chronisch obstruktiven Lungenerkrankung (PH-COPD). Pneumologie. 65(S 02). S125–S126. 1 indexed citations

Wilkens, Heinrike, Friedrich Grimminger, Marius M. Hoeper, et al.. (2010). Burden of pulmonary arterial hypertension in Germany. Respiratory Medicine. 104(6). 902–910. 40 indexed citations

10.

Stähler, G.. (2008). Spezifische Medikamente zur Behandlung der pulmonal-arteriellen Hypertonie – aktueller Stand. DMW - Deutsche Medizinische Wochenschrift. 133(S 06). S183–S186.

11.

King, Talmadge E., Jürgen Behr, Kevin M. Brown, et al.. (2007). BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 177(1). 75–81. 364 indexed citations

12.

Günther, Andreas, Philipp Markart, Peter Hammerl, et al.. (2007). Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study. European Respiratory Journal. 29(4). 713–719. 54 indexed citations

13.

Ehlken, B., Hossein Ardeschir Ghofrani, Friedrich Grimminger, et al.. (2007). PRS6 ECONOMIC BURDEN OF DISEASE OF PULMONARY ARTERIAL HYPERTENSION IN GERMANY: AN INTERIM ANALYSIS OF RESOURCE UTILISATION. Value in Health. 10(6). A308–A308. 2 indexed citations

14.

Stähler, G., et al.. (2006). Successful treatment of portopulmonary hypertension with bosentan: case report. European Journal of Clinical Investigation. 36(s3). 62–66. 8 indexed citations

15.

Seeger, Werner, et al.. (1983). Alteration of Pressure-Volume Characteristics due to Different Types of Edema Induction in Isolated Rabbit Lungs. Respiration. 44(4). 273–281. 4 indexed citations

16.

Seeger, Werner, H. Wolf, G. Stähler, H. Neuhof, & L Róka. (1982). Increased pulmonary vascular resistance and permebility due to arachidonate metabolism in isolated rabbit lungs. Prostaglandins. 23(2). 157–173. 53 indexed citations

17.

Wolf, H., Werner Seeger, G. Stähler, H. Neuhof, & L Róka. (1981). Protektiver Effekt der antioxidativ wirksamen Chromanstruktur des Tocopherols auf die Folgen stimulierter Arachidonsäure-Freisetzung in der pulmonalen Strombahn. Journal of Molecular Medicine. 59(9). 463–465. 1 indexed citations

18.

Seeger, Werner, H. Wolf, G. Stähler, H. Neuhof, & L Róka. (1981). Zunahme des Strömungswiderstandes und der Gefäßpermeabilität in der pulmonalen Strombahn als Folge des Metabolismus freier Arachidonsäure. Journal of Molecular Medicine. 59(9). 459–461. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact